ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

CRVS Corvus Pharmaceuticals Inc

1.73
0.12 (7.45%)
取引時間後
最終更新日: 06:31:33
15分遅延
名称 銘柄コード 市場 種別
Corvus Pharmaceuticals Inc CRVS NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.12 7.45% 1.73 06:31:33
始値 安値 高値 終値 前日終値
1.76 1.68 1.78 1.73 1.61
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0305:02GLOBECorvus Pharmaceuticals to Provide Business Update and First..
2024/5/0221:30GLOBECorvus Pharmaceuticals Announces Pricing of $30.6 Million..
2024/4/1005:01GLOBECorvus Pharmaceuticals Announces Initiation of..
2024/3/2005:02GLOBECorvus Pharmaceuticals Provides Business Update and Reports..
2024/3/1920:27IHMARKETNEWSUS Index Futures Decline Ahead of Federal Reserve Meeting,..
2024/3/1405:02GLOBECorvus Pharmaceuticals to Provide Business Update and Fourth..
2024/3/0207:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1222:30GLOBECorvus Pharmaceuticals Presents Soquelitinib Preclinical..
2024/2/0906:27EDGAR2Form 3 - Initial statement of beneficial ownership of..
2024/2/0906:05GLOBECorvus Pharmaceuticals Announces Orphan Drug Designation..
2024/2/0706:05GLOBECorvus Pharmaceuticals Appoints Jeffrey Arcara as Chief..
2024/1/2407:00EDGAR2Form 8-K - Current report
2024/1/2407:00GLOBECorvus Pharmaceuticals Announces the Passing of Board Member..
2023/12/1002:00GLOBECorvus Pharmaceuticals Presents New Interim Soquelitinib..
2023/12/0906:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/0906:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/0806:03EDGAR2Form 8-K - Current report
2023/11/0806:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0806:01GLOBECorvus Pharmaceuticals Provides Business Update and Reports..
2023/11/0222:15GLOBECorvus Pharmaceuticals to Present New Interim Soquelitinib..
2023/11/0208:31GLOBECorvus Pharmaceuticals Announces Publication of Preclinical..
2023/11/0105:02GLOBECorvus Pharmaceuticals to Provide Business Update and Report..
2023/9/0705:05GLOBECorvus Pharmaceuticals Confirms Planned Initiation of..
2023/8/0905:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0905:01EDGAR2Form 8-K - Current report
2023/8/0905:01GLOBECorvus Pharmaceuticals Provides Business Update and Reports..
2023/8/0121:30GLOBECorvus Pharmaceuticals to Provide Business Update and Report..
2023/7/0701:59GLOBECorvus Pharmaceuticals Announces Publication of Preclinical..
2023/6/2920:00GLOBECorvus Pharmaceuticals Presents New Ciforadenant Preclinical..
2023/6/1520:00GLOBECorvus Pharmaceuticals Presents New CPI-818 Interim Data at..
2023/5/3121:30GLOBECorvus Pharmaceuticals to Present at the Jefferies..
2023/5/1722:00GLOBECorvus Pharmaceuticals to Present New CPI-818 Data at the..
2023/5/0905:01GLOBECorvus Pharmaceuticals Provides Business Update and Reports..

最近閲覧した銘柄

Delayed Upgrade Clock